focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Aug 2010 08:50

RNS Number : 1119R
Phorm Inc
16 August 2010
 



16th August 2010

Phorm, Inc. ('Phorm' or 'the Company')

 

Phorm Announces Board Changes

 

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, announces the following changes to the Company's Board:

 

Mark Schneider is appointed to the Board as a Non-Executive Director. Mark was co-founder of leading European cable group UPC, which was subsequently acquired by Liberty Global in 2005. Mark has served on public and private company boards of companies operating in over 20 countries around the world, including United Artist Entertainment, UIH, UnitedGlobalCom, UPC, SBS Broadcasting and Blockbuster Video. With his background in international cable and telecommunications, Mark brings strong operating knowledge and an extensive network of contacts to the Board.

 

Kip Meek will step down from the Board with immediate effect. This follows Kip's previously announced appointment as Chairman of Project Canvas.

 

Kent Ertugrul, CEO of Phorm, commented, "I would like to thank Kip for his valuable insights and advice, which have contributed to the progress made by the Company since his appointment. We are sorry to see Kip go, but recognise that he needs to focus his energies on Project Canvas. We wish him well.

 

Meanwhile, we welcome Mark Schneider to the Board. He brings with him an in-depth understanding of media and telecommunications, has operated in multiple markets globally, and remains one of the pioneers of the international cable industry. We look forward to working with Mark to deliver on the substantial promise of our Company."

 

Save as set out in the Appendix, there are no further details in relation to the above appointment which require disclosure under paragraph (g) of Schedule 2 to the AIM rules.

 

Enquiries:

 

Phorm, Inc

Sarah Simon: +44 20 7297 2433 (analysts and investors)

Alex Laity: +44 20 7297 2710 (press)

 

Citigate Dewe Rogerson +44 20 7638 9571

Simon Rigby

Justin Griffiths

 

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Adviser)

Mark Williams

Andrew Chubb

 

 

Appendix:

 

Information provided in accordance with paragraph g of Schedule 2 to the AIM rules:

 

1. Details of full name, age, previous names:

 

Full Name: Mark Lyle Schneider

Age: 55

 

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner

 

General Media Services Limited - present

Schneider Media Africa Limited - present

Africa Telecommunications Media and Technology Fund 1 LLC - present

Big Sleep Hotels - present

Ricall Limited - present

Shorts Entertainment Limited - present

 

In addition, Mr Schneider has, in relation to this appointment as a Non-Executive Director, today been granted options over 150,000 shares of USD 0.001 each in the Company ("Ordinary Shares"), exercisable at a price of 137.5p per Ordinary Share. These options have a vesting period of four years, and expire ten years from the Date of Grant. Following this grant, Mr Schneider will have options over 200,000 Ordinary Shares.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGMRNVLGGZG
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.